Our Clinical Trials

There is evidence to suggest that cannabidiol (CBD) may be beneficial in the treatment of sleep disorders. Although this is positive, more research is required to investigate the therapeutic effect of CBD in reducing sleep disturbances. 

There is evidence to suggest that cannabidiol (CBD) may be beneficial in the treatment of sleep disorders. Although this is positive, more research is required to investigate the therapeutic effect of CBD in reducing sleep disturbances. 

There is evidence to suggest that cannabidiol (CBD) may be beneficial in the treatment of sleep disorders. Although this is positive, more research is required to investigate the therapeutic effect of CBD in reducing sleep disturbances. 

There is evidence to suggest that cannabidiol (CBD) may be beneficial in the treatment of sleep disorders. Although this is positive, more research is required to investigate the therapeutic effect of CBD in reducing sleep disturbances. 

This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.

This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.

The Boost Study is looking at a potential new vaccine for protection against the germs that cause meningitis.

This Phase 3, randomised, placebo-controlled, observer-blind clinical trial is designed to evaluate the safety, efficacy and immunogenicity of an investigational vaccine (mRNA-1647) for CMV in healthy volunteers.